Form 8-K - Current report:
SEC Accession No. 0001504776-24-000022
Filing Date
2024-11-07
Accepted
2024-11-07 06:48:32
Documents
14
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K wrby-20241107.htm   iXBRL 8-K 27651
2 EX-99.1 warbyparkerincearningsrele.htm EX-99.1 264540
  Complete submission text file 0001504776-24-000022.txt   443881

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wrby-20241107.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wrby-20241107_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wrby-20241107_pre.xml EX-101.PRE 13581
16 EXTRACTED XBRL INSTANCE DOCUMENT wrby-20241107_htm.xml XML 2814
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40825 | Film No.: 241433041
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)